Search Results 421-430 of 14103 for 78%
78 · 79 · 80 · 81 · 82 · 83 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials ...
76 · 77 · 78 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
2023 Oct; 78 (4):1064-1073.e1 Epub 2023 June 17. View PubMed; Farazdaghi A, Sen I, Anderson PB, Shuja F, Rasmussen TE. The Human Acellular Vessel (HAV) as a ...
An ETDRS BCVA letter score between ≤ 78 and ≥ 40 in the study eye 3. Diagnosis of subfoveal CNV secondary to AMD in the study eye previously treated with ...
77 · 78 · 79 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...
78 · 79 · 80 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...
77 · 78 · 79 ... Next · Last. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science · Healthcare Delivery ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.